New Lyme Test Gets Study

Commentary: A new Lyme test to detect early disease, called SpiroFind, is being evaluated by researchers at Columbia University. Present antibody testing misses approximately half of the patients with an early infection, when the disease is potentially curable. The test relies on the presence of inflammatory molecules called cytokines, which are produced during the infection. These cytokines are responsible for many of the clinical manifestations of Lyme disease, and are discussed in detail in my book in chapter seven, Lyme and Inflammation (pages 185-201).

New Lyme Test Gets Study, by Karl Rabe, Poughkeepsie Journal